Previous Article | Next Article 
Infection and Immunity, August 2001, p. 4951-4957, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4951-4957.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Monocytic Cell Activation by Nonendotoxic
Glycoprotein from Prevotella intermedia ATCC 25611 Is
Mediated by Toll-Like Receptor 2
Shunji
Sugawara,1,*
Shuhua
Yang,1
Koichi
Iki,2
Junko
Hatakeyama,1,3
Riyoko
Tamai,1
Osamu
Takeuchi,4
Sachiko
Akashi,5
Terje
Espevik,6
Shizuo
Akira,4 and
Haruhiko
Takada1
Department of Microbiology and
Immunology1 and Department of Operative
Dentistry,3 Tohoku University School of
Dentistry, Sendai 980-8575, Department of Periodontology,
Kagoshima University Dental School, Kagoshima
890-8544,2 Department of Host Defense,
Research Institute for Microbial Diseases, Osaka University, Osaka
565-0871,4 and Department of Immunology,
Saga Medical School, Saga 849-8501,5 Japan,
and Institute of Cancer Research and Molecular Biology,
Norwegian University of Science and Technology, Trondheim,
Norway6
Received 28 December 2000/Returned for modification 30 March
2001/Accepted 29 April 2001
 |
ABSTRACT |
Lipopolysaccharide (LPS) preparations from gram-negative
black-pigmented bacteria such as Porphyromonas
gingivalis and Prevotella intermedia activate
cells from non-LPS-responsive C3H/HeJ mice, but it is still unclear
whether this activity is due to the unique structure of LPS or to a
minor component(s) responsible for the activity in the preparation. A
nonendotoxic glycoprotein with bioactivity against cells from C3H/HeJ
mice was purified from a hot phenol-water extract of P.
intermedia ATCC 25611 and designated Prevotella
glycoprotein (PGP). Treatment of human monocytic THP-1 cells with 22-oxyacalcitriol (OCT) induced maturation and marked expression of CD14 on the cells, but the cells constitutively expressed
Toll-like receptor 2 (TLR2) and TLR4 on the cells irrespective of the
treatment. PGP induced a high level of interleukin-8 production at
doses of 100 ng/ml and higher in OCT-treated THP-1 cells compared with
Salmonella LPS, and the production was
significantly inhibited by anti-CD14 and anti-TLR2 but not anti-TLR4
antibodies. Consistent with this, TLR2-deficient murine
macrophages did not respond to PGP. It was also shown that
PGP activity on the THP-1 cells was LPS-binding protein dependent and
was inhibited by a synthetic lipid A precursor
IVA. These results indicate that PGP activates monocytic
cells in a CD14- and TLR2-dependent manner.
 |
INTRODUCTION |
CD14 is expressed mainly on monocytes and
neutrophils and has recently been shown to act as a pattern recognition
receptor for various bacterial cell surface components in addition to
lipopolysaccharide (LPS) (29, 45). LPS-binding protein
(LBP) in serum accelerates the binding of low concentrations of LPS to
CD14 (6, 32, 46). Since CD14 is a 55-kDa
glycosylphosphatidylinositol-anchored membrane protein that lacks
transmembrane and cytoplasmic domains, CD14 itself does not elicit
intracellular signaling events (41). Members of the
vertebrate Toll-like receptor (TLR) family, homologues of
Drosophila Toll, have been implicated as important to innate immune responses in vertebrates (22). Recently, the gene
responsible for the LPS nonresponsiveness of C3H/HeJ mice was mapped
(28, 30). In this mouse, proline at cytoplasmic position
712 of the TLR4 polypeptide chain was replaced with histidine, a
substitution which prevented LPS signaling in the mouse. Supporting
this evidence, overexpression of wild-type TLR4 but not mutant TLR4
from C3H/HeJ mice activates nuclear factor
B (11).
Several recent studies showed that TLR4 mediates signals of LPS and
that TLR2 mediates signals of other bacterial cell surface components,
such as peptidoglycan, lipoprotein, and lipoarabinomannan (11,
21, 28, 30, 33, 37, 38, 42, 48).
Gram-negative anaerobic black-pigmented bacteria (BPB) such as
Porphyromonas gingivalis and Prevotella
intermedia have been suggested to be the principal bacteria
associated with periodontal diseases (10, 34). LPS
specimens prepared from BPB and related bacteria (formerly called
Bacteroides species) have been reported to possess chemical
and biological properties different from those of LPSs from the family
Enterobacteriaceae (7, 20, 44). LPS specimens
extracted from BPB and related bacteria with hot phenol-water activate
macrophages and lymphocytes from both LPS-responsive C3H/HeN
and non-LPS-responsive C3H/HeJ (TLR4 mutant) mice (8, 13,
16), and the purified lipid A moiety of P. gingivalis LPS induced production of proinflammatory cytokines
from the cells of C3H/HeJ mice (26, 40). It has recently
been shown that purified P. gingivalis LPS activated
macrophages from TLR4-deficient mice (39),
suggesting that this type of LPS preparation interacts with molecules
other than TLR4.
We have recently isolated an immunobiologically active nonendotoxic
glycoprotein from a hot phenol-water extract of
P. intermedia ATCC 25611 and have designated it
Prevotella glycoprotein (PGP) (12).
PGP consists mainly of carbohydrate and protein and is devoid of fatty
acid. PGP showed strong mitogenicity to splenocytes and showed
cytokine-inducing activity in macrophages from C3H/HeJ as well
as C3H/HeN mice. In contrast, LPS extracted from the same bacterium
with a phenol-chloroform-petroleum ether (PCP) mixture exhibited strong
Limulus activity and activated only the cells from C3H/HeN
mice, and its activity was completely inhibited by polymixin B. The LPS
fraction extracted with hot phenol-water exhibited the properties
of both PGP and PCP-extracted LPS preparations. These findings
strongly suggested that the unique bioactivities of LPS
preparations extracted from BPB and related bacteria with hot
phenol-water reported to date were due to this type of material and not
to LPS itself. To further examine this possibility, we investigated whether PGP and LPS preparations from
P. intermedia can stimulate a human monocytic cell
line, THP-1 cells, and macrophages of TLR2- and
TLR4-deficient mice by interacting with CD14, TLR2, and TLR4.
 |
MATERIALS AND METHODS |
Reagents. (i) PGP preparation.
PGP was prepared from
P. intermedia ATCC 25611 as described previously
(12). Briefly, lyophilized cells of P. intermedia were extracted with phenol-water at 67°C, and the
extract in the water phase was ultracentrifuged at 140,000 × g. The LPS sediment was designated LPS-phenol-water
(LPS-PW). The supernatant was then applied to a column of Sephadex
G-100 (Pharmacia, Uppsala, Sweden), and the fractions free of
Limulus activity and mitogenic to C3H/HeJ splenocytes were
collected, treated with NP1 nuclease (Yamasa, Choshi, Japan), and
rechromatographed on Sephadex G-100 to obtain the final PGP fraction.
Another LPS preparation was extracted from the same bacteria with the
PCP mixture and designated LPS-PCP. The PGP fraction was scarcely
active in the Limulus test (22 ng/mg) (Endospecy test;
Seikagaku Co., Tokyo, Japan) (23) and contained rhamnose,
galactose, and glucose as neutral sugars and small amounts of
glucosamine as described previously (12). Chemical
analytical data for LPS-PW and LPS-PCP were also described in a
previous paper (12).
(ii) Other reagents.
An ultrapurified LPS preparation from
Salmonella enterica serovar Abortus-equi (Novo-Pyrexal)
(4) was a gift from C. Galanos (Max Plank Institut
für Immunbiologie, Freiburg, Germany) and was used as a reference
LPS of Enterobacteriaceae. A synthetic lipid A precursor
IVA, LA-14-PP (compound 406), was obtained
from Daiichi Chemical Co. (Tokyo, Japan). Anti-human TLR2
monoclonal antibody (MAb) TL2.1 (mouse immunoglobulin G2a [IgG2a])
and TLR4 MAb HTA125 (mouse IgG2a) were raised as described previously
(1, 35). Purified anti-human CD14 MAb MY4 (mouse IgG2b)
and isotype control IgG were purchased from Coulter (Miami, Fla.) and
dialyzed against phosphate-buffered saline. Recombinant human LBP
(rLBP) was purchased from Biometec (Greifswald, Germany). All other
reagents were obtained from Sigma (St. Louis, Mo.) unless otherwise indicated.
Cell line and mice.
THP-1, a human leukemia cell line of
monocyte/macrophage lineage, was obtained from Human Science
Research Resource Bank (Osaka, Japan) and grown in RPMI 1640 with 10%
fetal bovine serum (FBS) (heat inactivated at 56°C for 30 min) (Life
Technologies, Grand Island, N.Y.). To induce maturation, cultures were
grown in 24-well plates (Falcon; Becton Dickinson Labware, Lincoln
Park, N.J.) in the presence of 0.1 µM 22-oxyacalcitriol (OCT) (Chugai
Pharmaceutical Co., Tokyo, Japan) (17), a potent analogue
of 1,25-dihydroxyvitamin D3, for 3 days.
Mutant mice deficient in TLR2 and TLR4 were generated by gene targeting
as described previously (11, 37). Age-matched groups of
wild-type, TLR2-deficient, and TLR4-deficient mice on the same genetic
background were used for the experiments.
Flow cytometry.
Flow cytometric analyses were performed with
a fluorescence-activated cell sorter (FACScan; Becton Dickinson,
Mountain View, Calif.) (36). Briefly, cells were stained
with fluorescein isothiocyanate (FITC)-conjugated MY4 or
FITC-conjugated isotype control IgG2b (Coulter) at 4°C for 30 min.
For TLR2 and TLR4 staining, cells were treated with TL2.1, HTA125, or
isotype control IgG2a at 4°C for 30 min and then incubated with
FITC-conjugated goat anti-mouse IgG (BioSource International,
Camarillo, Calif.) at 4°C for a further 30 min.
Detection of cytokines by ELISA.
OCT-treated THP-1 cells
were seeded in a 96-well flat-bottomed plate (Falcon) at 5 × 104 cells/well and were incubated with or without
test stimulants in 200 µl of RPMI 1640 with 1% FBS for 24 h
(unless otherwise indicated) for interleukin-8 (IL-8)
production. For the inhibition experiments, the cells were preincubated
with given concentrations of MAbs or LA-14-PP for 30 min at 37°C and
then stimulated with test stimulants at 37°C in a
CO2 incubator. For the LBP dependency experiment,
the cells were stimulated in the presence or absence of 0.1 µg of
rLBP/ml in medium containing 0.1% bovine serum albumin (BSA) (Roche
Diagnostics, Mannheim, Germany). After the incubation, the
supernatants were collected and the level of IL-8 in the supernatants was determined with an OptEIA human IL-8 enzyme-linked immunosorbent assay (ELISA) set (PharMingen, San Diego, Calif.). The concentrations of IL-8 in the supernatants were determined using the Softmax data
analysis program (Molecular Devices Corp., Menlo Park, Calif.).
Measurement of tumor necrosis factor alpha (TNF-
) production from
murine macrophages was performed as described previously (37). Briefly, mice were intraperitoneally injected with 2 ml of 4% thioglycolate medium (Difco, Detroit, Mich.). Three days later, peritoneal exudate cells were isolated from the peritoneal cavity by washing with ice-cold Hanks' balanced salt solution (Life
Technologies). Cells were cultured for 2 h and washed with warmed
Hanks' balanced salt solution to remove nonadherent cells. Adherent
monolayer cells were used as peritoneal macrophages and were
cultured in RPMI 1640 medium with 10% FBS. Peritoneal
macrophages were cultured with 10 µg of stimulants per ml for
24 h. Concentrations of TNF-
in culture supernatants were
measured by ELISA according to the instructions of the manufacturer
(Genzyme/Techne, Minneapolis, Minn.)
Data analysis.
All of the experiments in this study were
conducted at least three times. The data shown are representative
results. Experimental values are given as means ± standard
deviations (SD) from triplicate cultures. The statistical significance
of differences between two means was evaluated by Student's unpaired
t test, and P values of less than 0.05 were
considered significant.
 |
RESULTS |
Effect of OCT on expression of CD14, TLR2, and TLR4 by THP-1
cells.
It has been shown that an active form of vitamin
D3 (1,25-dihydroxyvitamin
D3) and its potent analogue, OCT, induce
maturation of THP-1 cells and consequently expression of CD14 on the
cells (15, 47). Therefore, we first examined whether OCT
induces not only CD14 but also TLR2 and TLR4 by flow cytometry. When
THP-1 cells were incubated with 0.1 µM OCT for 3 days, a strong
induction of CD14 was observed on the cell surface (Fig.
1). By contrast, TLR2 and TLR4 were already expressed on
the untreated cell surface of THP-1 cells, and the expression was
almost unaffected after exposure to OCT. This observation was confirmed
by reverse transcription-PCR (data not shown). Based on this
observation, OCT-treated THP-1 cells were utilized in further
experiments.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
Effect of OCT on the expression of CD14, TLR2, and
TLR4 by THP-1 cells. THP-1 cells were incubated with or without
0.1 µM OCT for 3 days. Cells were stained with anti-CD14 MY4,
anti-TLR2 TL2.1, or anti-TLR4 HTA125 MAbs (solid lines) or with control
IgG (dotted lines) and were analyzed by flow cytometry. Similar results
were obtained from three distinct experiments.
|
|
Stimulation of THP-1 cells with PGP and P.
intermedia LPS preparations to produce IL-8.
We next
examined whether PGP and P. intermedia LPS preparations
stimulate THP-1 cells by measuring production of IL-8 from the cells.
The reference Salmonella serovar Abortus-equi LPS at 1 ng/ml
stimulated THP-1 cells to produce IL-8, and the production reached a
maximum at 10 ng/ml (Fig. 2A). PGP and P. intermedia LPS-PW at 100 ng/ml started to induce production of
IL-8 from the THP-1 cells, and the production was increased at higher
concentrations. By contrast, P. intermedia LPS-PCP
showed no effect on the cells. A time kinetic study showed that IL-8
production from the THP-1 cells in response to PGP and P. intermedia LPS-PW was time dependent, and the production was
highest at 24 h, showing a pattern similar to that for the
reference Salmonella serovar Abortus-equi LPS (Fig. 2B).
P. intermedia LPS-PCP had no effect on the production of IL-8 at any time point. It is notable that PGP and P. intermedia LPS-PW induced high levels of IL-8 at 100 ng/ml and
induced higher concentrations than the reference
Salmonella serovar Abortus-equi LPS.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 2.
IL-8 production from THP-1 cells in response to PGP and
P. intermedia LPS preparations. OCT-treated THP-1
cells were stimulated with the indicated concentrations of
Salmonella serovar Abortus-equi LPS, PGP, P.
intermedia LPS-PW, and P. intermedia
LPS-PCP for 24 h (A) or were stimulated with a 100-ng/ml
concentration of Salmonella serovar Abortus-equi LPS,
PGP, P. intermedia LPS-PW, and
P. intermedia LPS-PCP for the times
indicated (B). The culture supernatants were collected and analyzed for
the presence of IL-8 by ELISA. Error bars indicate SD. Results are
representative of those from four distinct experiments with similar
results.
|
|
Inhibition of PGP activity by anti-CD14 and anti-TLR2 MAbs but not
by anti-TLR4 MAb.
It has recently been shown that LPS activity was
CD14 and TLR4 dependent (11, 28, 30, 37, 42), and
therefore, we next examined the CD14 and TLR dependency of THP-1 cell
activation by PGP using neutralizing MAbs. The reference
Salmonella serovar Abortus-equi LPS (100 ng/ml)-induced
production of IL-8 from the THP-1 cells was significantly inhibited not
only by anti-CD14 but also by anti-TLR4 MAbs (Fig. 3),
as recently reported for human monocytes (36). By
contrast, the production induced by PGP (100 ng/ml) and P. intermedia LPS-PW (100 ng/ml) was significantly inhibited by
anti-CD14 MAb but not by anti-TLR4 MAb. In addition, anti-TLR2 MAb
significantly inhibited PGP- and P. intermedia
LPS-PW-induced but not the reference Salmonella serovar
Abortus-equi LPS-induced production of IL-8 from the cells (Fig.
4). These results suggest that PGP activates human
monocytic cells via a CD14- and TLR2-dependent but TLR4-independent
pathway.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of anti-CD14 and anti-TLR4 MAbs on PGP-induced
IL-8 production from THP-1 cells. OCT-treated THP-1 cells were
stimulated with a 100-ng/ml concentration of Salmonella
serovar Abortus-equi LPS, PGP, and P.
intermedia LPS-PW in the presence or absence of
anti-CD14 MAb MY4 (10 µg/ml), its isotype control mouse IgG2b (10 µg/ml), anti-TLR4 MAb HTA125 (5 µg/ml), or its isotype control
mouse IgG2a (5 µg/ml) for 24 h. The culture supernatants were
collected and analyzed for the presence of IL-8 by ELISA. Error bars
indicate SD. **, P < 0.01 versus stimulants
alone. Results are representative of those from three distinct
experiments with similar results.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of anti-TLR2 MAb on PGP-induced IL-8 production
from THP-1 cells. OCT-treated THP-1 cells were stimulated with a
100-ng/ml concentration of Salmonella serovar
Abortus-equi LPS, PGP, or P.
intermedia LPS-PW in the presence or absence of
anti-TLR2 MAb TL2.1 (10 µg/ml) or its isotype control mouse IgG2a (10 µg/ml) for 24 h. The culture supernatants were collected and
analyzed for the presence of IL-8 by ELISA. Error bars indicate SD.
**, P < 0.01 versus stimulants alone. Results
are representative of those from three distinct experiments with
similar results.
|
|
Responsiveness of TLR2- and TLR4-deficient murine peritoneal
macrophages to PGP.
In order to confirm the
above-described observations obtained with human monocytic cells in
culture and the previous observation that PGP activates cells from
non-LPS-responsive C3H/HeJ mice (12), the responsiveness
of peritoneal macrophages of TLR2- and TLR4-deficient mice to
PGP was next examined by measuring TNF-
production. P. intermedia LPS-PW induced TNF-
production from the cells of
both wild-type and TLR4-deficient mice and lesser amounts from the
cells of TLR2-deficient mice (Fig. 5). Although P. intermedia LPS-PCP had no effect on human
monocytic THP-1 cells, as shown in Fig. 2A, it induced
TNF-
production in macrophages from wild-type mice,
and the responses of both TLR2- and TLR4-deficient mice were reduced by
approximately 50% compared with those of wild-type mice. The residual
TLR2- and TLR4-mediated responses to LPS-PCP may be attributable to an
endotoxin protein(s) and LPS itself, respectively, because the LPS-PCP
contained marked amounts of protein (12) and lipoprotein
activates cells through TLR2 (9, 38). By contrast, PGP
induced TNF-
production from both wild-type and TLR4-deficient
macrophages but had no effect on the production of TNF-
from
the cells of TLR2-deficient mice, indicating clearly that PGP activity
is TLR2 dependent.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 5.
Responsiveness of murine peritoneal macrophages
to PGP and P. intermedia LPS preparations.
Peritoneal macrophages from wild-type, TLR2-deficient, and
TLR4-deficient mice were cultured with a 10-µg/ml concentration of
PGP, P. intermedia LPS-PW (PW), or
P. intermedia LPS-PCP (PCP) for
24 h. Concentrations of TNF- in the culture supernatants were
measured by ELISA. ND, Not detected. The results are representative of
those from three different experiments with similar results.
|
|
PGP activity is LBP dependent.
Since LBP in serum accelerated
the binding of low concentrations of LPS to CD14 (6, 32,
46), we next examined the possible involvement of LBP in
PGP-induced cell activation. The reference Salmonella
serovar Abortus-equi LPS-induced IL-8 production from the THP-1 cells
was significantly augmented in the presence of 100 ng of rLBP/ml in the
medium with 0.1% BSA (Fig. 6). IL-8 production from the
THP-1 cells induced by PGP and P. intermedia LPS-PW was also significantly augmented at 10 and 100 ng/ml. By contrast, P. intermedia LPS-PCP did not induce production of IL-8
even in the presence of rLBP. These results indicated that even
though PGP is different from LPS in chemical structure, PGP activity was enhanced in the presence of LBP.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 6.
PGP activity is LBP dependent. OCT-treated THP-1 cells
were incubated with the indicated concentrations of
Salmonella serovar Abortus-equi LPS, PGP, P.
intermedia LPS-PW, and P.
intermedia LPS-PCP in medium supplemented with 0.1% BSA
in the presence (closed circles) or absence (open circles) of 100 ng of
human rLBP/ml for 24 h. The amounts of IL-8 in the supernatants
were analyzed by ELISA. Error bars indicate SD. *,
P < 0.05; **, P < 0.01 (versus without LBP). The results are representative of those from
three different experiments with similar results.
|
|
Lipid IVA acts as an antagonist of PGP.
We
next analyzed whether synthetic lipid IVA
(LA-14-PP or compound 406), a well-known LPS antagonist in human cells,
inhibits the activity of PGP. The THP-1 cells were
stimulated with the reference Salmonella serovar
Abortus-equi LPS (100 ng/ml) or PGP (100 ng/ml) with or
without different concentrations of LA-14-PP for 24 h. As shown in
Fig. 7, IL-8 production induced by PGP as well as LPS
was inhibited by LA-14-PP in a dose-dependent manner, and almost
complete inhibitions of LPS and PGP activities were observed at a
10-fold excess amount of LA-14-PP, indicating that LA-14-PP acts as an
antagonist not only of LPS but also of PGP.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 7.
LA-14-PP acts as an antagonist against LPS and PGP.
OCT-treated THP-1 cells were stimulated with Salmonella
serovar Abortus-equi LPS (100 ng/ml) (A) or PGP (100 ng/ml) (B) in the
presence or absence of LA-14-PP at the indicated concentrations
for 24 h. The amounts of IL-8 in the supernatants were analyzed
by ELISA. Error bars indicate SD. *, P < 0.05; **, P < 0.01 (versus stimulant alone).
The results are representative of those from three different
experiments with similar results.
|
|
 |
DISCUSSION |
It has been reported that LPS specimens extracted from BPB and
related bacteria with hot phenol-water exert unique biological activities on human and murine cells. In particular, the BPB-derived LPS preparations activated cells from non-LPS-responsive C3H/HeJ mice
as well as LPS-responsive C3H/HeN mice (8, 13, 16, 26,
40). However, it is still unclear whether the unique biological activity of the BPB and related bacterial LPS is due to differences in
the chemical structure of the LPS, especially the lipid A portion, compared to that of Enterobacteriaceae LPS or to a minor
component(s) in the LPS preparations specific to BPB and related
bacteria, which are responsible for the apparent activities of these
LPS preparations (see the discussion in reference 12). The
PGP used in this study consisted mainly of rhamnose, galactose, and
glucose as neutral sugars, with small amounts of glucosamine
(12). PGP contains only trace amounts of fatty acids and
shows very little activity in the Limulus test (22 ng/mg)
(12), indicating that PGP was not contaminated by LPS. The
LPS-PW and LPS-PCP used in this study showed Limulus
activity comparable to that of reference Escherichia coli
LPS (12), but LPS-PCP showed no IL-8-inducing activity in
human monocytic cells (Fig. 2). In contrast, LPS-PW exhibited the same
activity as PGP on the cells (Fig. 2), and LPS-PW exhibited the
properties of both PGP and LPS-PCP in murine cells (12),
suggesting that the unique bioactivities of LPS preparations of BPB and
related bacteria reported to date are derived from some PGP-like
molecule(s). In support of this possibility, a chemically synthesized
P. gingivalis lipid A activated macrophages to
produce IL-6 and TNF-
from C3H/HeN mice but not from C3H/HeJ mice
(25).
It has been documented that established protocols for isolating LPS
with hot phenol-water result in the coextraction of capsular polysaccharide complex (CPC) of Bacteroides fragilis
(27) and that the purified CPC induced IL-1, IL-8, and
TNF-
production from human and murine monocytes/macrophages
(5). Although the chemical structure of PGP has not been
defined, PGP consists mainly of carbohydrate and protein and is devoid
of fatty acid, and the activity was resistant to heat (100°C, 1 h) and protease (pronase E) treatment but sensitive to periodate
treatment (12), suggesting that (i) PGP is not a endotoxin
protein, (ii) the carbohydrate but not the protein moiety of PGP was
important for the activity, and (iii) PGP might be a member of the CPC,
a unique constituent of BPB and related bacteria (formerly called
Bacteroides species). Friedman et al. previously reported a
bioactive carbohydrate-rich fraction of Serratia marcescens
that was devoid of endotoxic activity (2, 3), suggesting
that there is some similarity between these fractions and
that a carbohydrate-rich fraction with bioactivity may be
distributed among other bacterial species.
P. intermedia LPS-PCP did not induce IL-8 production in
human monocytic THP-1 cells (Fig. 2) but activated murine
macrophages to induce TNF-
and IL-6 production (Fig. 5)
(12). The chemical structure of lipid A of P. gingivalis was proposed by two groups (18, 24). These
groups noted considerable variations concerning the lipid A structure,
but the P. gingivalis lipid A possesses fewer and
longer fatty acids than the E. coli-type lipid A. The chemical analysis of P. intermedia LPS (LPS-PCP)
indicated structural similarity to P. gingivalis
LPS (12). It is conceivable that the biological
activity of P. intermedia LPS-PCP may have similarity to that of lipid IVA in human and murine
monocytic cells. Our preliminary study showed that P. intermedia LPS-PCP acts as an antagonist of LPS in human monocytic
cells, like lipid IVA (S. Yang, S. Sugawara, and
H. Takada, unpublished data).
Several recent studies showed that TLR4 mediates signals of LPS and
that TLR2 mediates signals of other bacterial cell surface components,
such as peptidoglycan, lipoprotein, and lipoarabinomannan (11,
21, 28, 30, 33, 37, 38, 42, 48). We have previously shown that
PGP activates cells from C3H/HeJ mice (TLR4 mutant) (12).
We showed in the present study that PGP strongly induced production of
IL-8 at a higher level than that induced by LPS from OCT-treated THP-1
cells, which express both TLR2 and TLR4, and that anti-CD14 and
anti-TLR2 but not anti-TLR4 MAbs inhibited PGP-induced production of
IL-8 from the cells (Fig. 3 and 4). This observation was supported by
the evidence in the murine system that TLR2-deficient
macrophages did not produce TNF-
in response to PGP (Fig.
5), indicating that PGP activates human and murine monocytic cells via
a CD14- and TLR2-dependent pathway.
Kitchens et al. (14, 15) suggested that lipid
IVA can antagonize LPS not only by competing to
bind CD14 and/or LBP but also by interacting at a site distal to CD14,
and recently Lien et al. (19) demonstrated that lipid
IVA antagonized LPS-induced cell activation in
Chinese hamster ovary fibroblasts overexpressing human CD14 and TLR4
but not TLR2, indicating that lipid IVA competes with LPS to bind CD14 and TLR4. However, gram-positive bacterial cell
wall components such as peptidoglycan and lipoarabinomannan activate
cells via the CD14-TLR2 pathway (21, 33, 37), and both
activities were also blocked by lipid IVA
(31, 43), probably competing with CD14. Therefore, it is
possible that complete inhibition of PGP activity on THP-1 by lipid
IVA (Fig. 7) resulted from competition to bind
CD14, probably because of the low affinity of PGP for CD14. Even though
the chemical structure of PGP is different from that of LPS, PGP
activity was enhanced in the presence of LBP (Fig. 6), suggesting that
PGP activity is LBP dependent. In support of this observation, it has
been shown that LBP also enhanced the sensitivity of THP-1 cells to a
TLR2 ligand, lipoarabinomannan (31).
In conclusion, we have proposed that BPB and related bacteria possess
unique PGP-like molecules, and in the course of purification of LPS by
established protocols, these molecules may be coisolated in the LPS
preparation and are probably responsible for the unique bioactivity of
BPB and the related bacterial LPS fraction. In the present study, we
showed that nonendotoxic glycoprotein from periodontopathic
P. intermedia activated human monocytic cells with
different usage of TLRs from LPS.
 |
ACKNOWLEDGMENTS |
We thank C. Galanos for providing an LPS preparation and Ø.
Halaas and R. Ryan, Norwegian University of Science and Technology, for
helpful discussion on the TL2.1 MAb.
This work was supported in part by Grants-in Aid for Scientific
Research from the Ministry of Education, Science, Sports, and Culture,
Japan (10470378, 11671796, and 12470380).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Tohoku University School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. Phone: 81-22-717-8306. Fax: 81-22-717-8309. E-mail:
sugawars{at}mail.cc.tohoku.ac.jp.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Flo, T. H.,
Ø. Halaas,
E. Lien,
L. Ryan,
G. Teti,
D. T. Golenbock,
A. Sundan, and T. Espevik.
2000.
Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide.
J. Immunol.
164:2064-2069[Abstract/Free Full Text].
|
| 2.
|
Friedman, H.,
D. K. Blanchard,
C. Newton,
T. W. Klein. Stewart, 2nd,
T. Keler, and A. Nowotny.
1987.
Distinctive immunomodulatory effects of endotoxin and nontoxic lipopolysaccharide derivatives in lymphoid cell cultures.
J. Biol. Response Mod.
6:664-677[Medline].
|
| 3.
|
Friedman, H.,
R. C. Butler, and A. Nowotny.
1987.
Enhanced antibody response in retrovirus-infected mice treated with endotoxin or nontoxic polysaccharide derivative.
Proc. Soc. Exp. Biol. Med.
186:275-279[Abstract].
|
| 4.
|
Galanos, C.,
D. Lüderitz, and O. Westphal.
1979.
Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal).
Zentbl. Bakteriol. Mikrobiol. Hyg. Abt. 1 Orig. Reihe A
243:226-244.
|
| 5.
|
Gibson, I. I. I.,
F. C.,
A. O. Tzianabos, and A. B. Onderdonk.
1996.
The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.
Infect. Immun.
64:1065-1069[Abstract].
|
| 6.
|
Hailman, E.,
H. S. Lichenstein,
M. M. Wurfel,
D. S. Miller,
D. A. Johnson,
M. Kelley,
L. A. Busse,
M. M. Zukowski, and S. D. Wright.
1994.
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
J. Exp. Med.
179:269-277[Abstract/Free Full Text].
|
| 7.
|
Hamada, S.,
H. Takada,
T. Ogawa,
T. Fujiwara, and J. Mihara.
1990.
Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties.
Int. Rev. Immunol.
6:247-261[Medline].
|
| 8.
|
Hanazawa, S.,
K. Nakada,
Y. Ohmori,
T. Miyoshi,
S. Amano, and S. Kitano.
1985.
Functional role of interleukin 1 in periodontal disease: induction of interleukin 1 production by Bacteroides gingivalis lipopolysaccharide in peritoneal macrophages from C3H/HeN and C3H/HeJ mice.
Infect. Immun.
50:262-270[Abstract/Free Full Text].
|
| 9.
|
Hirschfeld, M.,
Y. Ma,
J. H. Weis,
S. N. Vogel, and J. J. Weis.
2000.
Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2.
J. Immunol.
165:618-622[Abstract/Free Full Text].
|
| 10.
|
Holt, S. C., and T. E. Bramanti.
1991.
Factors in virulence expression and their role in periodontal disease pathogenesis.
Crit. Rev. Oral Biol. Med.
2:177-281[Abstract/Free Full Text].
|
| 11.
|
Hoshino, K.,
O. Takeuchi,
T. Kawai,
H. Sanjo,
T. Ogawa,
Y. Takeda,
K. Takeda, and S. Akira.
1999.
Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
J. Immunol.
162:3749-3752[Abstract/Free Full Text].
|
| 12.
|
Iki, K.,
K. Kawahara,
S. Sawamura,
R. Arakaki,
T. Sakuta,
A. Sugiyama,
H. Tamura,
T. Sueda,
S. Hamada, and H. Takada.
1997.
A novel component different from endotoxin extracted from Prevotella intermedia ATCC 25611 activates lymphoid cells from C3H/HeJ mice and gingival fibroblasts from humans.
Infect. Immun.
65:4531-4538[Abstract].
|
| 13.
|
Kirikae, T.,
T. Nitta,
F. Kirikae,
Y. Suda,
S. Kusumoto,
N. Qureshi, and M. Nakano.
1999.
Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS.
Infect. Immun.
67:1736-1742[Abstract/Free Full Text].
|
| 14.
|
Kitchens, R. L., and R. S. Munford.
1995.
Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway.
J. Biol. Chem.
270:9904-9910[Abstract/Free Full Text].
|
| 15.
|
Kitchens, R. L.,
R. J. Ulevitch, and R. S. Munford.
1992.
Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
J. Exp. Med.
176:485-494[Abstract/Free Full Text].
|
| 16.
|
Koga, T.,
T. Nishihara,
T. Fujiwara,
T. Nishizawa,
N. Okahashi,
T. Noguchi, and S. Hamada.
1985.
Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli.
Infect. Immun.
47:638-647[Abstract/Free Full Text].
|
| 17.
|
Kubodera, N.,
K. Sato, and Y. Nishii.
1997.
Characteristics of 22-oxacalcitriol (OCT) and 2b-(3-hydroxypropoxy)-calcitriol (ED-71), p. 1071-1086.
In
D. Feldman, F. H. Glorieux, and J. W. Pike (ed.), Vitamin D. Academic Press, San Diego, Calif.
|
| 18.
|
Kumada, H.,
Y. Haishima,
T. Umemoto, and K. Tanamoto.
1995.
Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis.
J. Bacteriol.
177:2098-2106[Abstract/Free Full Text].
|
| 19.
|
Lien, E.,
T. K. Means,
H. Heine,
A. Yoshimura,
S. Kusumoto,
K. Fukase,
M. J. Fenton,
M. Oikawa,
N. Qureshi,
B. Monks,
R. W. Finberg,
R. R. Ingalls, and D. T. Golenbock.
2000.
Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
J. Clin. Investig.
105:497-504[Medline].
|
| 20.
|
Lindberg, A. A.,
A. Weintraub,
U. Zähringer, and E. T. Rietschel.
1990.
Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis.
Rev. Infect. Dis.
12:S133-S141.
|
| 21.
|
Means, T. K.,
E. Lien,
A. Yoshimura,
S. Wang,
D. T. Golenbock, and M. J. Fenton.
1999.
The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors.
J. Immunol.
163:6748-6755[Abstract/Free Full Text].
|
| 22.
|
Medzhitov, R.,
P. Preston-Hurlburt, and C. A. Janeway, Jr.
1997.
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.
Nature
388:394-397[CrossRef][Medline].
|
| 23.
|
Obayashi, T.,
H. Tamura,
S. Tanaka,
M. Ohki,
S. Takahashi,
M. Arai,
M. Masuda, and T. Kawai.
1985.
A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications.
Clin. Chim. Acta
149:55-65[CrossRef][Medline].
|
| 24.
|
Ogawa, T.
1993.
Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide.
FEBS Lett.
332:197-201[CrossRef][Medline].
|
| 25.
|
Ogawa, T.,
Y. Asai,
H. Yamamoto,
Y. Taiji,
T. Jinno,
T. Kodama,
S. Niwata,
H. Shimauchi, and K. Ochiai.
2000.
Immunobiological activities of a chemically synthesized lipid A of Porphyromonas gingivalis.
FEMS Immunol. Med. Microbiol.
28:273-281[CrossRef][Medline].
|
| 26.
|
Ogawa, T.,
H. Shimauchi,
H. Uchida, and Y. Mori.
1996.
Stimulation of splenocytes in C3H/HeJ mice with Porphyromonas gingivalis lipid A in comparison with enterobacterial lipid A.
Immunobiology
196:399-414[Medline].
|
| 27.
|
Pantosti, A.,
A. O. Tzianabos,
A. B. Onderdonk, and D. L. Kasper.
1991.
Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.
Infect. Immun.
59:2075-2082[Abstract/Free Full Text].
|
| 28.
|
Poltorak, A.,
X. He,
I. Smirnova,
M.-Y. Liu,
C. Van Huffel,
X. Du,
D. Birdwell,
E. Alejos,
M. Silva,
C. Galanos,
M. Freudenberg,
P. Ricciardi-Castagnoli,
B. Layton, and B. Beutler.
1998.
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
Science
282:2085-2088[Abstract/Free Full Text].
|
| 29.
|
Pugin, J.,
D. Heumann,
A. Tomasz,
V. V. Kravchenko,
Y. Akamatsu,
M. Nishijima,
M. P. Glauser,
P. S. Tobias, and R. J. Ulevitch.
1994.
CD14 is a pattern recognition receptor.
Immunity
1:509-516[CrossRef][Medline].
|
| 30.
|
Qureshi, S. T.,
L. Larivi,
G. Leveque,
S. Clermont,
K. J. Moore,
P. Gros, and D. Malo.
1999.
Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4).
J. Exp. Med.
189:615-625[Abstract/Free Full Text].
|
| 31.
|
Savedra, R., Jr.,
R. L. Delude,
R. R. Ingalls,
M. J. Fenton, and D. T. Golenbock.
1996.
Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the signaling system.
J. Immunol.
157:2549-2554[Abstract].
|
| 32.
|
Schumann, R. R.,
S. R. Leong,
G. W. Flaggs,
P. W. Gray,
S. D. Wright,
J. C. Mathison,
P. S. Tobias, and R. J. Ulevitch.
1990.
Structure and function of lipopolysaccharide binding protein.
Science
249:1429-1431[Abstract/Free Full Text].
|
| 33.
|
Schwandner, R.,
R. Dziarski,
H. Wesche,
M. Rothe, and C. J. Kirschning.
1999.
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2.
J. Biol. Chem.
274:17406-17409[Abstract/Free Full Text].
|
| 34.
|
Shah, H. N.,
D. Mayrand, and R. Genco (ed.).
1993.
Biology of the species Porphyromonas gingivalis.
CRC Press, Inc., Boca Raton, Fla.
|
| 35.
|
Shimazu, R.,
S. Akashi,
H. Ogata,
Y. Nakagi,
K. Fukudome,
K. Miyake, and M. Kimoto.
1999.
MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.
J. Exp. Med.
189:1777-1782[Abstract/Free Full Text].
|
| 36.
|
Sugawara, S.,
E. Nemoto,
H. Tada,
K. Miyake,
T. Imamura, and H. Takada.
2000.
Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness.
J. Immunol.
165:411-418[Abstract/Free Full Text].
|
| 37.
|
Takeuchi, O.,
K. Hoshino,
T. Kawai,
H. Sanjo,
H. Takada,
T. Ogawa,
K. Takeda, and S. Akira.
1999.
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.
Immunity
11:443-451[CrossRef][Medline].
|
| 38.
|
Takeuchi, O.,
A. Kaufmann,
K. Grote,
T. Kawai,
K. Hoshino,
M. Morr,
P. F. Mühlradt, and S. Akira.
2000.
Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway.
J. Immunol.
164:554-557[Abstract/Free Full Text].
|
| 39.
|
Takeuchi, O.,
K. Takeda,
K. Hoshino,
O. Adachi,
T. Ogawa, and S. Akira.
2000.
Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades.
Int. Immunol.
12:113-117[Abstract/Free Full Text].
|
| 40.
|
Tanamoto, K.,
S. Azumi,
Y. Haishima,
H. Kumada, and T. Umemoto.
1997.
The lipid A moiety of Porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice.
J. Immunol.
158:4430-4436[Abstract].
|
| 41.
|
Ulevitch, R. J., and P. S. Tobias.
1995.
Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.
Annu. Rev. Immunol.
13:437-457[CrossRef][Medline].
|
| 42.
|
Underhill, D. M.,
A. Ozinsky,
A. M. Hajjar,
A. Stevens,
C. B. Wilson,
M. Bassetti, and A. Aderem.
1999.
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.
Nature
401:811-815[CrossRef][Medline].
|
| 43.
|
Weidemann, B.,
H. Brade,
E. T. Rietschel,
R. Dziarski,
V. Bazil,
S. Kusumoto,
H.-D. Flad, and A. J. Ulmer.
1994.
Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures.
Infect. Immun.
62:4709-4715[Abstract/Free Full Text].
|
| 44.
|
Wilson, M.
1993.
Biological activities of lipopolysaccharide and endotoxin, p. 171-197.
In
H. N. Shah, D. Mayrand, and R. J. Genco (ed.), Biology of the species Porphyromonas gingivalis. CRC Press, Inc., Boca Raton, Fla.
|
| 45.
|
Wright, S. D.
1995.
CD14 and innate recognition of bacteria.
J. Immunol.
155:6-9[Medline].
|
| 46.
|
Wright, S. D.,
R. A. Ramos,
P. S. Tobias,
R. J. Ulevitch, and J. C. Mathison.
1990.
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
Science
249:1431-1433[Abstract/Free Full Text].
|
| 47.
|
Yang, S.,
R. Tamai,
S. Akashi,
O. Takeuchi,
S. Akira,
S. Sugawara, and H. Takada.
2001.
Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.
Infect. Immun.
69:2045-2053[Abstract/Free Full Text].
|
| 48.
|
Yoshimura, A.,
E. Lien,
R. R. Ingalls,
E. Tuomanen,
R. Dziarski, and D. Golenbock.
1999.
Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
J. Immunol.
163:1-5[Abstract/Free Full Text].
|
Infection and Immunity, August 2001, p. 4951-4957, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4951-4957.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Asai, Y., Ohyama, Y., Taiji, Y., Makimura, Y., Tamai, R., Hashimoto, M., Ogawa, T.
(2005). Treponema medium Glycoconjugate Inhibits Activation of Human Gingival Fibroblasts Stimulated with Phenol-Water Extracts of Periodontopathic Bacteria. J. Dent. Res.
84: 456-461
[Abstract]
[Full Text]
-
Hashimoto, M., Asai, Y., Ogawa, T.
(2004). Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis. Int Immunol
16: 1431-1437
[Abstract]
[Full Text]
-
Uehara, A., Sugawara, S., Watanabe, K., Echigo, S., Sato, M., Yamaguchi, T., Takada, H.
(2003). Constitutive Expression of a Bacterial Pattern Recognition Receptor, CD14, in Human Salivary Glands and Secretion as a Soluble Form in Saliva. CVI
10: 286-292
[Abstract]
[Full Text]
-
Mambula, S. S., Sau, K., Henneke, P., Golenbock, D. T., Levitz, S. M.
(2002). Toll-like Receptor (TLR) Signaling in Response to Aspergillus fumigatus. J. Biol. Chem.
277: 39320-39326
[Abstract]
[Full Text]
-
Lee, H.-K., Lee, J., Tobias, P. S.
(2002). Two Lipoproteins Extracted from Escherichia coli K-12 LCD25 Lipopolysaccharide Are the Major Components Responsible for Toll-Like Receptor 2-Mediated Signaling. J. Immunol.
168: 4012-4017
[Abstract]
[Full Text]
-
Fox-Marsh, A., Harrison, L. C.
(2002). Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system. J. Leukoc. Biol.
71: 401-409
[Abstract]
[Full Text]